Next-generation sequencing of prostate tumors: Use of individualised biomarkers for prognosis and treatment- Martin Spahn

Next-generation sequencing of prostate tumors: Use of individualised biomarkers for prognosis and treatment (STOP 6)

Biography:
Martin Spahn, MD